| Biomarker ID | 831 |
| PMID | 22189868 |
| Year | 2011 |
| Biomarker | sPLA2-IIA (Secreted group IIA phospholipase A2) |
| Biomarker Basis | Concentration Based (μg/L) |
| Biomolecule | Protein |
| Source | Serum |
| Subjects | Humans |
| Regulation | Upregulated in Prostate cancer |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways Include:-Alpha-linolenic acid metabolism,Ether lipid metabolism,Phosphatidic acid biosynthesis,Acyl chain remodelling of phosphatidylcholine,Linoleic acid metabolism |
| Experiment | Controls Vs Prostate Cancer |
| Type of Biomarker | Diagnostic |
| Cohort | 25 patients with Prostate cancer and 25 with BPH, and 40 controls (healthy individuals) were also chosen. |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.001 |
| Method Used | ELISA |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | PLA2G2A |